Connect with others who understand.

Sign up Log in
Resources
About mySMAteam
Powered By

Spinal Muscular Atrophy Type 4

Medically reviewed by Evelyn O. Berman, M.D.
Written by Laurie Berger
Updated on May 26, 2021

Spinal muscular atrophy (SMA) is a rare genetic neuromuscular disorder that causes low muscle tone (hypotonia) and progressive muscle weakness and wasting (atrophy). Depending on SMA type, severity, and age of onset, SMA can affect motor skills like walking, as well as eating and breathing.

SMA type 4, known as adult-onset SMA, is the mildest type of SMA. It accounts for fewer than 5 percent of SMA cases, according to the Muscular Dystrophy Association (MDA). SMA type 4 typically begins in adulthood and leads to mild motor impairment.

What Is SMA Type 4?

There are five main types of spinal muscular atrophy. In SMA types 0-2, symptoms typically appear in the womb or in infants and young children. People with SMA types 0-2 can have difficulty sucking, swallowing, and breathing, as well as major motor impairment. In utero, this can be noted by limited movement and increased amniotic fluid. Newborns with SMA might also have limb contractures at birth.

SMA type 3 can begin in childhood through early adulthood. People with SMA type 3 (Kugelberg-Welander disease) experience mobility impairment, but rarely have respiratory difficulties.

SMA type 4 generally occurs after age 35 — although symptoms can appear as early as the late teens, according to Cure SMA. Adult-onset SMA symptoms tend to be milder, and may include hand and finger tremors, achy or heavy muscles, numbness, and cramping. SMA type 4 rarely involves the swallowing and breathing dysfunction characteristic of SMA type 0 or 1.

While other types of SMA can severely limit mobility, people with SMA type 4 usually remain mobile into their 60s. In later years, some may need a wheelchair or motorized device to get around. Those with SMA type 4 tend to have a life expectancy similar to that of the general population.

Causes of SMA Type 4

Spinal muscular atrophy is caused by a genetic mutation on both copies of the survival motor neuron 1, or SMN1 gene. That mutation inhibits the production of SMN proteins, which maintain normal functioning of motor neurons. Motor neurons are nerve cells that enable messaging between the brain, spinal cord, and muscles. Without functioning motor neurons, the brain cannot send signals to the muscles, which leads to muscle wasting, or atrophy.

A second gene, called the SMN2 gene, also produces a small amount of SMN protein. The number of copies of SMN2 a person has — and the amount of SMN protein they produce — can influence the type and severity of SMA.

Symptoms of SMA Type 4

Symptoms of SMA type 4 are similar to those of SMA type 3, but with milder muscle weakness. Typical symptoms include:

  • Tired, aching muscles
  • Feelings of heaviness in the limbs
  • Numbness
  • Cramps
  • Twitches and tremors in fingers and hands
  • Fatigue

SMA type 4 typically starts in the leg and hip muscles, progressing steadily and slowly toward the shoulders and arms. As with all forms of SMA, weakness increases over time. Although the level of disability can vary, studies have shown that people with SMA type 4 generally do not develop severe disabilities.

Diagnosis of SMA Type 4

Diagnosing SMA type 4 can take some time. That’s because symptoms are typically mild and may require additional tests to rule out other neuromuscular conditions.

A neurologist will take a medical history, conduct a physical exam, and order a DNA blood test to confirm SMA. Genetic testing looks for the absence of the SMN1 gene, or mutations on that gene. In approximately 95 percent of SMA cases, the SMN1 gene is missing entirely.

Other diagnostic tests may include:

  • Electromyography (EMG) to measure how well nerves are controlling the muscles
  • Muscle biopsy to detect any muscle cell reduction
  • Nerve conduction velocity to measure the speed at which the nerve sends signals to the muscle
  • Magnetic resonance imaging (MRI) and computerized tomography (CT) scans to produce detailed images of the body’s tissues and structures

Treatments for SMA Type 4

Once a diagnosis of SMA type 4 has been confirmed, a neurologist may prescribe medication or physical therapy, or recommend nutritional or lifestyle changes. The goal of treatment is to keep a person healthy and mobile throughout their lives.

Medication

Spinraza (nusinersen) is approved by the U.S. Food and Drug Administration (FDA) for SMA in children and adults. Administered by injection into the fluid surrounding the spinal cord, Spinraza is believed to work by increasing the body’s production of SMN protein. Studies have shown the drug improves motor function in all types of SMA, including later-onset SMA. Spinraza has not been studied specifically in people with SMA type 4.

Clinical trials currently investigating new SMA treatments for adults include studies of the following drugs:

  • Valproic acid
  • 4-aminopyridine
  • Risdiplam
  • Pyridostigmine
  • Reldesemtiv
  • Olesoxime

Physical Therapy

Physical therapy (also called physiotherapy or PT) is designed to help people manage movement dysfunction, improve functional ability, and prevent future disability. People with SMA type 4 are advised to get as much physical activity as is possible and comfortable, to maintain mobility and independence throughout their lives.

A physical therapist can design an exercise plan to help people with SMA type 4 manage symptoms, like muscle weakness and contractures, or learn practices for safer, more efficient walking.

Muscle Weakness

Aquatic therapy, also known as hydrotherapy or water therapy, is among the therapies recommended by the International Standard of Care Committee for Spinal Muscular Atrophy to help maintain muscle strength and support stamina. It can be done in a bathtub, swimming pool, or hydrotherapy pool. Water buoyancy makes it possible to perform certain exercises that may not be possible on land.

Contractures

Range of motion exercises and regular stretching can help increase flexibility and prevent painful contractures (the permanent shortening and tightening of joints). Flexibility and range of motion are important for everyone with SMA, regardless of mobility levels. If necessary, a physical therapist will recommend splints, braces, and standing devices.

Gait Training

Some people with SMA unconsciously adapt their gait to compensate for muscle weakness. This puts strain on other parts of the body, impacting balance and long-term walking ability. Although people with SMA type 4 rarely develop walking problems, gait training can help them maintain mobility longer and walk more safely.

Occupational Therapy

Occupational therapy can help people with SMA 4 who’ve lost muscle strength to perform daily activities, such as dressing, using the computer, or completing home tasks. This might include learning alternative ways to put on clothing or learning to use assistive devices.

Respiratory Therapy

Although SMA type 4 does not normally cause breathing or swallowing problems, learning breathing exercises can boost general health and well-being. Respiratory function can also be improved by swimming or exercising in a hydrotherapy pool.

Diet and Nutrition

Reduced mobility and lack of exercise can cause weight gain in people with all types of SMA. Extra weight can put stress on muscles, bones, and joints, making it harder to exercise. Although SMA type 4 rarely causes difficulty with chewing and swallowing, a dietitian can customize a nutrition plan to help you maintain a healthy weight.

Self-Care

Individuals with SMA type 4 sometimes experience pain and fatigue when certain muscles are overused to compensate for weaker ones. A hot-water bottle or heating pad can help relax muscles, while a cold pack may be used for pain relief. Preventing your body from becoming overly tired can help manage fatigue. Meditation and mindfulness practices may also be helpful in managing pain and fatigue.

Assistive Equipment

Most people with SMA type 4 remain mobile throughout their lives, but some people may eventually need assistive devices if walking becomes difficult. A wheelchair can improve quality of life by reducing fatigue and fear of falling.

References
  1. Spinal Muscular Atrophy — Genetics Home Reference
  2. Physical Therapy Guide to Spinal Muscular Atrophy — ChoosePT
  3. Spinal Muscular Atrophy — Muscular Dystrophy Association
  4. Kugelberg Welander Syndrome — NORD
  5. Types of SMA — Muscular Dystrophy Association
  6. Types of SMA — Cure SMA
  7. Symptoms, Diagnosis & Effects of 5q Spinal Muscular Atrophy — Spinal Muscular Atrophy UK
  8. Spinal Muscular Atrophy — NORD
  9. SMN1 gene — Genetics Home Reference
  10. SMN2 gene — Genetics Home Reference
  11. Spinal Muscular Atrophy Type 4 — Spinal Muscular Atrophy Support UK
  12. Spinal Muscular Atrophy Type 3 — Muscular Dystrophy Australia
  13. Spinal muscular atrophy type 4 — Genetic and Rare Diseases Information Center
  14. Spinal Muscular Atrophy Type 4 — Muscular Dystrophy Australia
  15. Scoliosis in SMA — SMA Foundation
  16. Electromyography (EMG) — Mayo Clinic
  17. Simply Stated: Muscle Biopsies — Muscular Dystrophy Association
  18. Simply Stated: Electromyography and Nerve Conduction Velocities — Muscular Dystrophy Association
  19. Later-Onset Spinraza (nusinersen) Efficacy — Spinraza HCP
  20. ClinicalTrials.gov — U.S. National Library of Medicine
  21. Physical/Occupational Therapy — Spinal Muscular Atrophy Clinical Research Center
  22. Consensus Statement for Standard of Care in Spinal Muscular Atrophy — Journal of Child Neurology
  23. Spinal Muscular Atrophy — Section on Pediatrics, American Physical Therapy Association
  24. Look After Yourself If You’re an Adult Who Has Had a Recent Diagnosis of SMA — Spinal Muscular Atrophy UK
  25. Compensatory Mechanisms During Walking in Response to Muscle Weakness in Spinal Muscular Atrophy, Type III — Gait & Posture
  26. Therapy for Muscular Dystrophy — NYU Langone
Evelyn O. Berman, M.D. is a neurology and pediatric specialist and treats disorders of the brain in children. Review provided by VeriMed Healthcare Network. Learn more about her here.
Laurie Berger has been a health care writer, reporter, and editor for the past 14 years. Learn more about her here.

A mySMAteam Member

Very useful, good to see Sma 4 is becoming more high profile, good to see clinical trials being conducted, seems US far more advanced in combating it than UK but Smauk catching up

March 13
All updates must be accompanied by text or a picture.

We'd love to hear from you! Please share your name and email to post and read comments.

You'll also get the latest articles directly to your inbox.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy Policy
All updates must be accompanied by text or a picture.

Subscribe now to ask your question, get answers, and stay up to date on the latest articles.

Get updates directly to your inbox.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy Policy

Thank you for subscribing!

Become a member to get even more: